Sitagliptin Tablet, Film Coated
NDC Package 84677-050-90
Package Information
Sitagliptin tablets is are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Limitations of UseSitagliptin tablets should not be used in patients with type 1 diabetes.Sitagliptin has not been studied in patients with a history of pancreatitis. This formulation utilizes a tablet, film coated delivery system. Marketed by Golden State Medical Supply, Inc., this product is identified by NDC 84677-050 and is authorized under FDA application ANDA202425.
Identification & Billing
- RxCUI: 2709603 - SITagliptin phosphate 100 MG Oral Tablet
- RxCUI: 2709603 - sitagliptin phosphate 100 MG Oral Tablet
- RxCUI: 2709608 - SITagliptin phosphate 50 MG Oral Tablet
- RxCUI: 2709608 - sitagliptin phosphate 50 MG Oral Tablet
- RxCUI: 2709612 - SITagliptin phosphate 25 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 84677 - Golden State Medical Supply, Inc.
- 84677-050 - Sitagliptin
- 84677-050-90 - 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 84677-050 - Sitagliptin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84677-050-90 identifies a specific commercial package of 90 tablet, film coated in 1 bottle, plastic of Sitagliptin, a human prescription drug labeled by Golden State Medical Supply, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This tablet, film coated is formulated for oral use and contains sitagliptin phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Golden State Medical Supply, Inc. on January 20, 2026. The current certification is valid through December 31, 2027.
How is this Golden State Medical Supply, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84677005090. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.